Brett Leav

7.8k citations
37 papers · 2.0k · 2 hit papers · h-index 19

Impact in

    • Clostridium difficile and Clostridium perfringens research
    • Viral gastroenteritis research and epidemiology
    • SARS-CoV-2 and COVID-19 Research
    • Amoebic Infections and Treatments
    • Parasitic Infections and Diagnostics

Papers in

    • SARS-CoV-2 and COVID-19 Research 8
    • Viral gastroenteritis research and epidemiology 4
    • Clostridium difficile and Clostridium perfringens research 3
    • Influenza Virus Research Studies 11
    • Hepatitis B Virus Studies 3

Brett Leav

37 papers receiving 1.9k citations

Brett Leav's Hit Papers

The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials 2023 · 108 citations
1080+5+10Years since publication100200300400500

Peers

Brett Leav
Comparison fields: 5 of 91
  • Infectious Diseases 1.2k
  • Parasitology 294
  • Epidemiology 743
  • Hepatology 126
  • Critical Care and Intensive Care Medicine 59
Replace Jeffrey L. Silber with:
Jeffrey L. Silber United States
Nadine Rouphael United States
T. Christopher Mast United States
Camille N. Kotton United States
Szu‐Min Hsieh Taiwan
Delane Shingadia United Kingdom
Susanne Dudman Norway
Lena Grillner Sweden
Jin Han Kang South Korea
Chang-Phone Fung Taiwan
Brett Leav relative to Jeffrey L. Silber United States Jeffrey L. Silber's profile →
Citations per field
00.5×4.3×
Jeffrey L. Silber · 1×
Citations per year

Countries citing papers authored by Brett Leav

Since Specialization
Citations

This map shows the geographic impact of Brett Leav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett Leav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett Leav more than expected).

Fields of papers citing papers by Brett Leav

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett Leav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett Leav. The network helps show where Brett Leav may publish in the future.

Co-authors

The 25 scholars most cited alongside Brett Leav, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brett Leav Line = papers co-authored together Brett Leav links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Hit paper breakdown →
2010562
2 2009193
3 2002152
4 2021148
5 2012135
6
The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials
Hit paper breakdown →
2023108
7 202272
8 200372
9 202258
10 199654
11 201848
12 200540
13 201937
14 200535
15 202134
16 201234
17
Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats.
199329
18 202024
19 201322
20 202218

About Brett Leav

Brett Leav is a scholar working on Infectious Diseases, Epidemiology, Immunology, Parasitology and Radiology, Nuclear Medicine and Imaging, having authored 37 papers that have together received 2.0k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (11 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Parasitic Infections and Diagnostics (5 papers), Viral gastroenteritis research and epidemiology (4 papers), Hepatitis B Virus Studies (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Infectious Diseases (1.2k citations), Parasitology (294 citations), Epidemiology (743 citations), Hepatology (126 citations) and Critical Care and Intensive Care Medicine (59 citations). Brett Leav has collaborated with scholars based in United States, Philippines and United Kingdom. Frequent co-authors include Deborah C. Molrine, Barbra M. Blair, Donna M. Ambrosino, Mark D. Leney, Dale N. Gerding, Israel Lowy, Roger Baxter, Honorine Ward, William D. Thomas and Susan Sloan. Their work appears in journals such as Vaccine, Infection and Immunity, International Journal of Infectious Diseases, Nature Medicine and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact